Introduction to Critical Pharmacy Issues in Cancer and Thrombosis Prophylaxis: Pharmacologic Foundations of Patient Care
Pharmacy-Based DVT Risk Profiling in Cancer Patients: What Landmark Trials Teach the HSP About the Need for Pharmacologic Prophylaxis in the Setting of Malignancy: What Works? What Doesn’t?
ASCO and NCCN Guidelines for DVT Prophylaxis in Cancer Patients: The Hospital Pharmacist’s Perspective—Cost, Quality of Care, and Guideline Adherence: A Real World Pharmacy-Based Perspective
Fanikos, RPh, MBA
Pharmacologic Prophylaxis of DVT in Special Patient Populations: Dosing, Risks, and Strategies for Patients with Cancer and Associated Comorbid Conditions
Nutescu, PharmD, FCCP
Identifying Cancer Patients at Risk for DVT: Implementation of a Hospital-Based ALERT System for the Clinical Pharmacist and Medical Staff: A Collaborative Approach to Pharmacologic Thromboprophylaxis
QUESTION AND ANSWER SESSION